Adult Gliosarcoma: Clinical Trials

46 trials for Adult Gliosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

39 completed, 6 terminated, 1 withdrawn. 46 Phase 2, 20 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 246Completed 39, Terminated 6, Withdrawn 1
Phase 120Completed 17, Terminated 2, Withdrawn 1

Follow Adult Gliosarcoma: new trials by email Literature Review of Adult Gliosarcoma trials Research Report on Adult Gliosarcoma

Trials (filtered) newest first · largest first

All 46 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients
MSC11FCD - Glioblastoma, Adult Gliosarcoma
Phase 1 / Phase 2CompletedCHA University102020-06-242023-01-18
EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma
EGFRBi-Armed Autologous T Cells, Laboratory Biomarker Analysis - Adult Brain Glioblastoma, Adult Gliosarcoma
Phase 1 / Phase 2WithdrawnBarbara Ann Karmanos Cancer Institute2015-08-012016-02-15
Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma
radiation therapy, temozolomide, plerixafor - Adult Ependymoblastoma, Adult Giant Cell Glioblastoma
Phase 1 / Phase 2CompletedLawrence Recht302014-11-012018-10-23
NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
Bevacizumab, NovoTTF-l00A, Quality of Life Assessment - Adult Giant Cell Glioblastoma, Adult Glioblastoma
Phase 2CompletedCase Comprehensive Cancer Center252013-09-182025-02-17
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
18F-fludeoxyglucose (18F-FDG), 18F-FPPRGD2 - Adult Giant Cell Glioblastoma, Adult Glioblastoma
Phase 1 / Phase 2CompletedSanjiv Sam Gambhir252013-03-042019-10-03
Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma
dovitinib, laboratory biomarker analysis - Adult Giant Cell Glioblastoma, Adult Glioblastoma
Phase 2CompletedManmeet Ahluwalia, MD332012-12-202017-12-12
Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
bevacizumab, radiation therapy - Adult Giant Cell Glioblastoma, Adult Glioblastoma
Phase 2CompletedRadiation Therapy Oncology Group1822012-12-202022-12-29
Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
Anti-Endoglin Chimeric Monoclonal Antibody TRC105, Bevacizumab, Laboratory Biomarker Analysis - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)1162012-11-012018-05-23
Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme
aminolevulinic acid, therapeutic conventional surgery - Adult Giant Cell Glioblastoma, Adult Glioblastoma
Phase 2TerminatedMichael Vogelbaum, MD, PhD82012-05-012018-07-31
Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma
gamma-secretase/Notch signalling pathway inhibitor RO4929097, therapeutic conventional surgery, pharmacological study - Adult Giant Cell Glioblastoma, Adult Glioblastoma
Phase 2TerminatedNational Cancer Institute (NCI)472010-12-012017-05-03
RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma
gamma-secretase/Notch signalling pathway inhibitor RO4929097, bevacizumab, laboratory biomarker analysis - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma
Phase 1 / Phase 2TerminatedNational Cancer Institute (NCI)132010-12-012015-12-14
Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
3-Dimensional Conformal Radiation Therapy, Cediranib Maleate, Intensity-Modulated Radiation Therapy - Adult Glioblastoma, Adult Gliosarcoma
Phase 2CompletedNational Cancer Institute (NCI)2612010-02-262022-07-26
GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
vismodegib, therapeutic conventional surgery, laboratory biomarker analysis - Adult Giant Cell Glioblastoma, Adult Glioblastoma
Phase 2CompletedNational Cancer Institute (NCI)442010-02-012017-08-16
Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
Laboratory Biomarker Analysis, Perifosine, Temsirolimus - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)362010-01-272021-07-19
MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme
FMISO, MRI, PET - Adult Giant Cell Glioblastoma, Adult Glioblastoma
Phase 2CompletedNational Cancer Institute (NCI)502009-08-242019-04-08
Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
3-Dimensional Conformal Radiation Therapy, Cognitive Assessment, Laboratory Biomarker Analysis - Adult Giant Cell Glioblastoma, Adult Glioblastoma
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)1252009-07-102022-08-04
Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma
Bendamustine Hydrochloride, Quality-of-Life Assessment - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma
Phase 2CompletedUniversity of Washington452008-10-012017-07-07
Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme
vorinostat, therapeutic conventional surgery, bortezomib - Adult Giant Cell Glioblastoma, Adult Glioblastoma
Phase 2CompletedNational Cancer Institute (NCI)442008-07-012014-05-14
Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Cediranib Maleate, Diffusion Tensor Imaging, Diffusion Weighted Imaging - Adult Giant Cell Glioblastoma, Adult Glioblastoma
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)462008-04-012023-06-06
Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
R-(-)-gossypol acetic acid, laboratory biomarker analysis - Adult Giant Cell Glioblastoma, Adult Glioblastoma
Phase 2CompletedNational Cancer Institute (NCI)562008-01-012017-08-11

Showing 20 of 46. Sign in to see all of them.

Narrower conditions

Gliosarcoma (46)  ·  Glioblastoma (45)  ·  Brain Neoplasms (32)  ·  Astrocytoma (10)  ·  Oligodendroglioma (9)  ·  Glioma (5)  ·  Breast Neoplasms (1)  ·  Breast Neoplasms, Male (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Central Nervous System Neoplasms (1)  ·  Colonic Neoplasms (1)  ·  Esthesioneuroblastoma, Olfactory (1)  ·  Hypopharyngeal Neoplasms (1)  ·  Laryngeal Neoplasms (1)

Broader conditions

Neoplasms (46)  ·  Neoplasms by Histologic Type (46)  ·  Neoplasms, Glandular and Epithelial (46)  ·  Neoplasms, Nerve Tissue (46)  ·  Neoplasms, Neuroepithelial (46)  ·  Neuroectodermal Tumors (46)  ·  Neoplasms, Germ Cell and Embryonal (45)  ·  Glioma (41)  ·  Astrocytoma (35)  ·  Brain Diseases (33)  ·  Central Nervous System Diseases (33)  ·  Neoplasms by Site (33)  ·  Nervous System Diseases (33)  ·  Nervous System Neoplasms (33)  ·  Central Nervous System Neoplasms (32)

Interventions

Temozolomide (8)  ·  Radiotherapy (6)  ·  Bevacizumab (5)  ·  Erlotinib Hydrochloride (5)  ·  Radiation (5)  ·  Radiotherapy, Conformal (5)  ·  Sirolimus (5)  ·  temsirolimus (5)  ·  Radiotherapy, Intensity-Modulated (3)  ·  Sorafenib (3)  ·  Vorinostat (3)  ·  cediranib (3)  ·  2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (2)  ·  Cilengitide (2)  ·  Disulfides (2)

Sponsors

National Cancer Institute (NCI) (37)  ·  Barbara Ann Karmanos Cancer Institute (1)  ·  CHA University (1)  ·  Case Comprehensive Cancer Center (1)  ·  Lawrence Recht (1)  ·  Manmeet Ahluwalia, MD (1)  ·  Michael Vogelbaum, MD, PhD (1)  ·  Radiation Therapy Oncology Group (1)  ·  Sanjiv Sam Gambhir (1)  ·  University of Washington (1)

Countries

United States (44)  ·  Canada (1)  ·  Saudi Arabia (1)  ·  South Korea (1)

Top investigators

Evanthia Galanis (5)  ·  David Peereboom, MD (3)  ·  Howard Fine, MD (2)  ·  Mark Gilbert (2)  ·  Tracy Batchelor (2)  ·  Adam P. Dicker, MD, PhD (1)  ·  Andrew Lassman (1)  ·  Arnab Chakravarti (1)  ·  Charles Nock, MD (1)  ·  Christina Tsien (1)  ·  David Brachman (1)  ·  David Peereboom (1)  ·  Edward Pan, MD (1)  ·  Elizabeth Gerstner (1)  ·  Elizabeth R Gerstner, MD (1)

Results publications

PMID 25113840, PMID 18955445, PMID 20200024, PMID 20458050, PMID 21377994, PMID 21632852, PMID 22517399, PMID 23328813, PMID 24309981, PMID 24470557, PMID 25758746, PMID 25832688, PMID 25965900, PMID 26062933, PMID 26611425, PMID 27185374, PMID 29902200, PMID 30850872, PMID 31386061, PMID 33842889, PMID 36260832, PMID 38197800

NIH funding

U10CA025224 (8), U01CA062475 (7), U01CA062399 (6), U10CA021661 (6), U01CA137443 (5), U10CA180821 (3), U10CA180868 (2), N01CM62203 (1), N01CM62206 (1), N01CM62207 (1), P30CA006516 (1), P30CA008748 (1), P30CA015704 (1), P30CA016058 (1), P30CA022453 (1)